What's new

Human medicines European public assessment report (EPAR): Darzalex, daratumumab, Date of authorisation: 20/05/2016, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR): Darzalex, daratumumab, Date of authorisation: 20/05/2016, Revision: 24, Status: Authorised

Apr 10, 2025 - 15:28
 0
Human medicines European public assessment report (EPAR): Darzalex, daratumumab, Date of authorisation: 20/05/2016, Revision: 24, Status: Authorised
Human medicines European public assessment report (EPAR): Darzalex, daratumumab, Date of authorisation: 20/05/2016, Revision: 24, Status: Authorised
Read More

Tags:

Previous Article

QRD veterinary Appendix I - Adverse event (PhV) MSs reporting details

Next Article

Human medicines European public assessment report (EPAR): Supemtek Tetra (previo...

Related Posts

European Surveillance of Veterinary Antimicrobial Consumption (ESVAC): 2009 - 2023

European Surveillance of Veterinary Antimicrobial Consu...

Mar 31, 2025  0

Human medicines European public assessment report (EPAR): Zolsketil pegylated liposomal, doxorubicin, Date of authorisation: 31/05/2022, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 13, 2025  0

EMEA-002640-PIP01-19-M01

EMEA-002640-PIP01-19-M01

Feb 14, 2025  0